Deferiprone is an oral synthetic progestin that prevents estrogen-induced endometrial hyperplasia, which thins the lining of the uterus. Deferiprone tablets can treat dysmenorrhea, endometriosis, amenorrhea, dysfunctional uterine bleeding, habitual abortion, etc. It is contraindicated for those who have allergy to Deferiprone, those who have unexplained vaginal bleeding, those who are suspected of having sex hormone-related malignant tumors, and those who have severe hepatic impairment. Vaginal bleeding, breast pain, nausea, abdominal pain, menstrual disorders, headache, etc. may occur after taking Deferiprone. The application of Dydrogesterone needs to be used under the guidance of a professional doctor, and should not be applied blindly to avoid other adverse consequences.